Evidence map›Paper›PMID 26109799›Full record

ReviewWorld journal of gastroenterology2015

Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy.

Sebiha Ozkan, Yasin Ceylan, Orhan Veli Ozkan, Sule Yildirim

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 4 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 4 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. European S2k Guideline on Chronic PruritusActa dermato-venereologica · 2025
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Sexual dimorphism in the liver.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sebiha OzkanSebiha Ozkan, Yasin Ceylan, Sule Yildirim, Department of Obstetrics and Gynecology, School of Medicine, Kocaeli University, Izmit 41380, Kocaeli, Turkey.
Yasin CeylanSebiha Ozkan, Yasin Ceylan, Sule Yildirim, Department of Obstetrics and Gynecology, School of Medicine, Kocaeli University, Izmit 41380, Kocaeli, Turkey.
Orhan Veli OzkanSebiha Ozkan, Yasin Ceylan, Sule Yildirim, Department of Obstetrics and Gynecology, School of Medicine, Kocaeli University, Izmit 41380, Kocaeli, Turkey.
Sule YildirimSebiha Ozkan, Yasin Ceylan, Sule Yildirim, Department of Obstetrics and Gynecology, School of Medicine, Kocaeli University, Izmit 41380, Kocaeli, Turkey.
Creative Research Enterprises (United States) · USKocaeli Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrahepatic cholestasis of pregnancy (ICP) is a reversible pregnancy-specific cholestatic condition characterized by pruritus, elevated liver enzymes, and increased serum bile acids. It commences usually in the late second or third trimester, and quickly resolves after delivery. The incidence is higher in South American and Scandinavian countries (9.2%-15.6% and 1.5%, respectively) than in Europe (0.1%-0.2%). The etiology is multifactorial where genetic, endocrine, and environmental factors interact. Maternal outcome is usually benign, whereas fetal complications such as preterm labor, meconium staining, fetal distress, and sudden intrauterine fetal demise not infrequently lead to considerable perinatal morbidity and mortality. Ursodeoxycholic acid is shown to be the most efficient therapeutic agent with proven safety and efficacy. Management of ICP consists of careful monitoring of maternal hepatic function tests and serum bile acid levels in addition to the assessment of fetal well-being and timely delivery after completion of fetal pulmonary maturity. This review focuses on the current concepts about ICP based on recent literature data and presents an update regarding the diagnosis and management of this challenging issue.

Indexed as

Cholestasis, IntrahepaticPregnancy ComplicationsCholagogues and CholereticsFemaleGenetic MarkersGenetic Predisposition to DiseaseHumansIncidencePhenotypePredictive Value of TestsPregnancyRisk FactorsTreatment OutcomeUrsodeoxycholic AcidCholagogues and CholereticsGenetic MarkersUrsodeoxycholic AcidCholestasisDiagnosisIntrahepaticManagementPregnancy

Identifiers

PMID26109799
PMCPMC4476874
OpenAlexW2354506521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.